Post by
pierrelebel on Dec 14, 2023 11:58am
In the meantime, Genting is moving up
Trading prices in Genting (the largest shareholder in TauRx) have jumped about 17% in the last 6 weeks from 4.01myr to 4.71myr this morning in Malasia.
Do they know something we do not (yet)?
Comment by
Macpoor on Jan 08, 2024 9:12pm
Great news! Although, we are trading under a buck! Cheers
Comment by
TheCount11 on Jan 09, 2024 9:41am
"It is understood that TauRx has submitted its lead investigative drug hydromethylthionine mesylate (HMTM) for consideration for approval in the UK via the Medicines and Healthcare Products Regulatory Agency." I am skeptical. Is there a list? eg Canada has Submissions Under Review (SUR) list while US FDA has New Drug Applications (NDAs) list.
Comment by
Catscratch on Jan 09, 2024 4:55pm
I am skeptical as well but I think that's to be expected with drug approvals. If TauRx is a zero I don't there is much downside for Dundee. But if HMTM gets approval and a TauRx valuation anywhere near US$15B is realized, Dundee's stock will soar.
Comment by
jrj90620 on Jan 13, 2024 2:35pm
Borborema should provide some income. https://www.globenewswire.com/news-release/2023/08/30/2734833/0/en/Aura-Minerals-Completes-Feasibility-Study-for-the-Borborema-Project-and-Increases-Ownership-Stake-in-Borborema-Inc-to-100.html
Comment by
TheCount11 on Jan 16, 2024 6:05am
Happy New Year Mac! I am unhappy with myself more than anythinng. Dundee has a history of nearly every investment turning out poorly not sure why I thought TauRx would be any different. My thesis was Dundee 2.0 would give funds that want exposure to jr gold miners a one stop shop. It had cheap capital in the form of prefs, no debt and traded at a discount to book value!
Comment by
pierrelebel on Jan 16, 2024 11:45am
"I am unhappy with myself more than anythinng." Ditto